When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to FDA Peptide Reclassification 2026: What It Means for Providers RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Ars Technica The Peptide Ban Is Ending: FDA Peptides Explained Apple Podcasts